| |
 |
|
Class Information
Number: 536/24.5
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Carbohydrates or derivatives > Nitrogen containing > N-glycosides, polymers thereof, metal derivatives (e.g., nucleic acids, oligonucleotides, etc.) > Dna or rna fragments or modified forms thereof (e.g., genes, etc.) > Nucleic acid expression inhibitors
Description: Fragments of DNA or RNA which are effective inhibitors of transcription or translation.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7045284 |
Method for selective inactivation of viral replication |
May. 16, 2006 |
| 7045293 |
Alteration of sequence of a target molecule |
May. 16, 2006 |
| 7045331 |
EGVII endoglucanase and nucleic acids encoding the same |
May. 16, 2006 |
| 7045616 |
Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease |
May. 16, 2006 |
| 7041816 |
Process for the synthesis of oligomeric compounds |
May. 9, 2006 |
| 7041817 |
Synthesis, deprotection, analysis and purification of RNA and ribozymes |
May. 9, 2006 |
| 7041484 |
Starch branching enzymes |
May. 9, 2006 |
| 7041507 |
Transdiffentiation of transfected epidermal basal cells into neural progenitor cells, neuronal cells and/or glial cells |
May. 9, 2006 |
| 7041654 |
Methods and compositions for inducing tumor-specific cytotoxicity |
May. 9, 2006 |
| 7037646 |
Amine-derivatized nucleosides and oligonucleosides |
May. 2, 2006 |
| 7038036 |
Oligonucleotides labeled with stable isotopes and a method for detecting the same |
May. 2, 2006 |
| 7033753 |
Compositions and methods for nonenzymatic ligation of oligonucleotides and detection of genetic polymorphisms |
Apr. 25, 2006 |
| 7033829 |
Method to inhibit cell growth using oligonucleotides |
Apr. 25, 2006 |
| 7033830 |
Antisense modulation of MyD88 expression |
Apr. 25, 2006 |
| 7034007 |
Low adenosine anti-sense oligonucleotide, compositions, kit & method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) & surfactant depleti |
Apr. 25, 2006 |
| 7034009 |
Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R) |
Apr. 25, 2006 |
| 7030236 |
Antisense oligonucleotides tarageting folate receptor alpha, and the use thereof |
Apr. 18, 2006 |
| 7026301 |
Method of orally treating inflammatory skin conditions with prodrugs of 5-fluorouracil |
Apr. 11, 2006 |
| 7026461 |
Engineered protein kinases which can utilize nucleotide triphosphate substrates |
Apr. 11, 2006 |
| 7022831 |
Regulation of BCL-2 gene expression |
Apr. 4, 2006 |
| 7022832 |
Oligonucleotides containing an antisense sequence stabilized by a secondary structure, pharmaceutical compositions containing them and method of blocking gene expression using them |
Apr. 4, 2006 |
| 7018984 |
Methods and compositions for controlling translation of HCV proteins |
Mar. 28, 2006 |
| 7015315 |
Gapped oligonucleotides |
Mar. 21, 2006 |
| 7005258 |
Cdc25 genes, encoded products and uses thereof |
Feb. 28, 2006 |
| 7005423 |
Characterization of gene function using double stranded RNA inhibition |
Feb. 28, 2006 |
| 7001723 |
Catalytic RNAs with aminoacylation activity |
Feb. 21, 2006 |
| 7001999 |
Tumor associated nucleic acids and uses therefor |
Feb. 21, 2006 |
| 7002003 |
Method for the inhibition of function of STAT transcription factors |
Feb. 21, 2006 |
| 6994959 |
G-rich oligo aptamers and methods of modulating an immune response |
Feb. 7, 2006 |
| 6995146 |
Compositions and methods for treatment of hepatitis C virus-associated diseases |
Feb. 7, 2006 |
| 6995258 |
Nucleolar targeting of therapeutics against HIV |
Feb. 7, 2006 |
| 6995300 |
Isolation of SU1, a starch debranching enzyme, the product of the maize gene sugary1 |
Feb. 7, 2006 |
| 6989270 |
Using polyamide nucleic acid oligomers to engender a biological response |
Jan. 24, 2006 |
| 6986988 |
Method for enrichment of natural antisense messenger RNA |
Jan. 17, 2006 |
| 6987177 |
Modified oligonucleotides, their preparation and their use |
Jan. 17, 2006 |
| 6984729 |
Oligonucleotides specific for hepatitis B virus |
Jan. 10, 2006 |
| 6977244 |
Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
Dec. 20, 2005 |
| 6974865 |
C3' -methylene hydrogen phosphonate oligomers and related compounds |
Dec. 13, 2005 |
| 6972171 |
Antisense oligonucleotide preparation method |
Dec. 6, 2005 |
| 6969588 |
Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
Nov. 29, 2005 |
| 6969704 |
Methods for suppressing early growth response--1protein (Egr-1) to reduce vascular injury in a subject |
Nov. 29, 2005 |
| 6964950 |
Antisense modulation of C-reactive protein expression |
Nov. 15, 2005 |
| 6965025 |
Antisense modulation of connective tissue growth factor expression |
Nov. 15, 2005 |
| 6962984 |
IgA nephropathy-related DNA |
Nov. 8, 2005 |
| 6960568 |
Nucleosides and related processes, pharmaceutical compositions and methods |
Nov. 1, 2005 |
| 6958239 |
Three component chimeric antisense oligonucleotides |
Oct. 25, 2005 |
| 6956117 |
Self-replicating RNA molecule from hepatitis C virus |
Oct. 18, 2005 |
| 6953783 |
Modulation of gene expression by combination therapy |
Oct. 11, 2005 |
| 6949378 |
C. elegans gro-1 gene |
Sep. 27, 2005 |
| 6949379 |
Aptamer-mediated regulation of gene expression |
Sep. 27, 2005 |
|
|
|
